Table 1.

Characteristics of patients analyzed

Characteristics	N (%)
Patients	17 (100.0)
Age (years) at first IPI cycle (median, range)	62.0 (33.0–88.2)
Sex
Male	11 (64.7)
Female	6 (35.3)
Primary melanoma subtype
Cutaneous	15 (88.2)
Mucosal	1 (5.9)
Unknown	1 (5.9)
ECOG performance status
0	16 (94.1)
> 0	1 (5.9)
Serum LDH
Normal level	9 (53.0)
≥ Upper limit of normal (ULN)	4 (23.5)
Unknown	4 (23.5)
Brain metastases
Absent	14 (82.4)
Present	3 (17.6)

IPI ipilimumab, ECOG-PS Eastern Cooperative Oncology Group-Performance Status, LDH, lactate dehydrogenase